UPMC Hillman Cancer Center Passavant (HOA)

Pittsburgh, Pennsylvania 15237

1 studies enrolling now · 5 studies all time

What they study most

Colorectal Neoplasms, Non-small Cell Lung Cancer, Primary Invasive Breast Cancer, Triple Negative Breast Cancer, mCRPC

Studies at this site

• A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer — Recruiting now
• Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC — Running, not enrolling
• An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer — Completed
• Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo — Running, not enrolling
• EndoPredict® Extended Endocrine Trial (EXET) — Stopped early